Hormone therapy increased risk for mortality in older men with prostate cancer treated with brachytherapy

Potters, Louis
October 2008
Hem/Onc Today;10/25/2008, Vol. 9 Issue 19, p26
The article discusses a study which showed increased risk for mortality in older men with prostate cancer treated with brachytherapy. The results of the study were presented by Amy Dosoretz, a resident at the Harvard Radiation Oncology Program. The percentage of increase in the risk for dying among older men who were treated by hormone therapy is indicated. The association between hormone therapy prior to brachytherapy and increased risk for all-cause mortality is also stated.


Related Articles

  • Advances in small molecule inhibitors of androgen receptor for the treatment of advanced prostate cancer. Sadar, Marianne // World Journal of Urology;Jun2012, Vol. 30 Issue 3, p311 

    Objectives: Current treatments for localized prostate cancer include brachytherapy, external beam radiation, surgery, and active surveillance. Unfortunately, 20-40% of prostate cancer patients will experience recurrence and require hormonal therapies. These therapies involve androgen ablation by...

  • Resection After Brachytherapy Is Considered Safe for Patients With History of Prostate Cancer.  // Clinical Journal of Oncology Nursing;Dec2004, Vol. 8 Issue 6, p588 

    States that patients with prostate cancer who have been treated with brachytherapy can undergo transurethral resection of the prostate safely after the treatment, according to researchers who published their study in the July 2004 issue of the "Journal of Urology." Study on patients who...

  • Evaluating interstitial radiation therapy for prostate carcinoma. Ellis, Rod J.; Resnick, Martin I. // Contemporary Urology;Apr2001, Vol. 13 Issue 4, p12 

    Discusses the use of brachytherapy for the treatment of prostate carcinoma. Advantages and disadvantages to any of available isotopes used in prostate brachytherapy; Techniques for transperineal implantation; Post-operative evaluation; Results; Conclusion.

  • New prostate treatment may increase awareness. Berkman, Sue // Westchester County Business Journal;7/26/99, Vol. 38 Issue 30, p21 

    Reports on developments in the treatment of prostate cancer. Adoption of the prostate-specific antigen test for early detection of prostate cancer; Seed implant or radioisotope brachytherapy that involves implanting of radioactive palladium.

  • Long-term brachytherapy data build. Guttman, Cheryl // Urology Times;Oct95, Vol. 23 Issue 10, p15 

    Focuses on the use of brachytherapy as treatment for prostate cancer. Development of techniques to enhance the use of brachytherapy; Treatment outcomes.

  • Brachytherapy may not be indicated in higher-risk PCa patients. Guttman, Cheryl // Urology Times;Nov98, Vol. 26 Issue 11, p3 

    Details findings of a retrospective cohort study from the University of Pennsylvania which cautions urologists about overapplying interstitial seed implantation or brachytherapy as a definitive treatment for localized prostate cancer. Use of multivariable analytic techniques to compare...

  • Will seeds soon replace scalpels for treating prostate cancer? Overmyer, Mac // Urology Times;Jan97, Vol. 25 Issue 1, p40 

    Reports on the use of brachytherapy for treating organ-confined prostate cancer. Results in patients who underwent brachytherapy with Iodine 125 seeds; Low postoperative morbidity; Side effects.

  • Brachytherapy's appeal leads to improved technology. Scheck, Anne // Urology Times;May99, Vol. 27 Issue 5, p14 

    Reports on the technological improvements in the field of prostate cancer treatment due to the increasing popularity of permanent prostate brachytherapy (PPB). Potential improvement of dose calculation modes; Improvement of image handling and display; Introduction of innovative methods of...

  • Several options viable if seed implants fail. Scheck, Anne // Urology Times;May99, Vol. 27 Issue 5, p14 

    Reports on doctor Bradley R. Prestidge's claims about the viability of several options for the treatment of prostate cancer after the failure of brachytherapy. Determination of the cause of the failure; Necessity of knowing the extent and grade of the tumor by histopathologic techniques;...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics